Sarah Anderson

Jun 1, 2024 | latrobebulletinnews.com | Sarah Anderson

Joanne Metz has called Latrobe home for the last 100 years. Living in the same house her whole life, she likes to joke that the house is younger than her. Metz has been able to pass down her memories from growing up during the Great Depression, World War II and Pearl Harbor, to name a few historical events. She even has a story to share about a brief passing by with Frank Sinatra. In an interview with the Latrobe Bulletin, Metz shared some life advice about the people we encounter in the world.

May 20, 2024 | latrobebulletinnews.com | Sarah Anderson

Alexis Jean Coletti is passionate about advocacy and change for the betterment of humanity. She is a Greater Latrobe School District alumna and recently graduated from Duquesne University with a number of accolades. As the recipient of the 2024 McAnulty College of Liberal Arts General Excellence Award, she was chosen as the valedictorian speaker for the McAnulty College of Liberal Arts graduation ceremony that took place on May 10.

May 2, 2024 | legallycyber.com | Sarah Anderson

A few binged seasons of Law & Order will teach you that you have a Constitutional right, under the 5th Amendment to remain silent: you have the right to refuse to give any self-incriminating statement or testimony. With this constitutional right available to individuals and companies alike, how does the Cyber Incident Reporting for Critical Infrastructure Act (CIRCIA) lawfully impose certain reporting requirements?

Mar 6, 2024 | legallycyber.com | Sarah Anderson

Too often, the focus following a data breach or other type of cyber incident is communicating with the public and specifically, consumers. Businesses are rightly concerned about economic losses associated with operational interruptions, loss of goodwill, and potential lawsuits from consumers. Unfortunately, the businesses’ own employees are overlooked as liability sources. Despite privacy policies often directed at the public, as well as current and future customers, they also apply to employees.

Oct 31, 2023 | neurologylive.com | Jeffrey Cohen |Sarah Anderson |Alicyn Magruder |Matt Hoffman

WATCH TIME: 12 minutesThe treatment paradigm for multiple sclerosis (MS) has come a long way since the early years of ABCR agents, with a therapeutic arsenal of disease-modifying therapies now numbering in the 20s. Yet, with all of the change that advances in pharmaceutical development have brought, there are still novel approaches being introduced—and perhaps the biggest recent introduction is biosimilars.